Combining literature reports and our results of bioinformatics and RT-qPCR, we hold that EPHX2 and FDPS are the oncogenes, while GBP1, MMD and ZYX are the anti-oncogene in osteosarcoma. This evidence concerns the gene MMD and osteosarcoma.